Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × Docosahexaenoic Acids × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Psoriasis 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Paget's Disease, Mammary 1 Osteoarthritis 1 Obesity 1 Neoplasms 1 Neoplasm, Residual 1 Fatigue 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Cancer Cachexia 1 Breast Carcinoma In Situ 1 Barrett Esophagus 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Aggressive Periodontitis 1

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡